Jin and colleagues, in a multicenter registry including 5143 patients with CCS, reported a significant association between elevated Lp(a) and the risk of adverse cardiovascular events in both non-diabetic patients and in those with pre-diabetes or diabetes[10]. This evidence concerns the gene LPA and diabetes mellitus.